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ADP-ribosyltransferases (ARTs) catalyze the transfer
of ADP-ribose from NAD+ onto substrates. Some
ARTs generate in an iterative process ADP-ribose
polymers that serve as adaptors for distinct protein
domains. Other ARTs, exemplified by ARTD10, func-
tion as mono-ADP-ribosyltransferases, but it has
been unclear whether this modification occurs in
cells and how it is read. We observed that ARTD10
colocalized with ARTD8 and defined its macrodo-
mains 2 and 3 as readers of mono-ADP-ribosylation
both in vitro and in cells. The crystal structures of
these two ARTD8 macrodomains and isothermal
titration calorimetry confirmed their interaction
with ADP-ribose. These macrodomains recognized
mono-ADP-ribosylated ARTD10, but not poly-ADP-
ribosylated ARTD1. This distinguished them from
the macrodomain of macroH2A1.1, which interacted
with poly- but notmono-ADP-ribosylated substrates.
Moreover, Ran, an ARTD10 substrate, was also read
by ARTD8 macrodomains. This identifies readers of
mono-ADP-ribosylated proteins, defines their struc-
tures, and demonstrates the presence of this modifi-
cation in cells.
INTRODUCTION
Protein ADP-ribosylation regulates diverse processes including
chromatin remodeling, transcription control, DNA repair, and
signaling (Gibson and Kraus, 2012; Hottiger et al., 2010). The
’’writers’’ are mono- and poly-ADP-ribosyltransferases (ARTs)
that modify specific protein targets. Recent studies demonstrate
that poly-ADP-ribose (PAR) synthesized by ARTD1/PARP1 (see
Hottiger et al., 2010 for definition of new nomenclature) and462 Structure 21, 462–475, March 5, 2013 ª2013 Elsevier Ltd All righARTD5 (Tankyrase) serve as protein-binding sites. For example,
ARTD1, activated and PARylated in response to DNA damage,
recruits DNA repair proteins through PAR-binding macrodo-
mains and PBZ domains (Ahel et al., 2008; Eustermann et al.,
2010; Gottschalk et al., 2009; Karras et al., 2005; Kleine and
Lu¨scher, 2009; Timinszky et al., 2009). Furthermore, the ubiquitin
E3 ligase RNF146/Iduna interacts with several PARylated
proteins via its WWE domain, resulting in RNF146 activation
and ubiquitination of the PARylated proteins (Kang et al.,
2011). As an example, ARTD5 PARylates axin, a key scaffold
protein in the WNT signaling pathway, which recruits RNF146
(Callow et al., 2011; Huang et al., 2009; Zhang et al., 2011).
3BP2 is also substrate of ARTD5 that subsequently becomes
substrate of RNF146. 3BP2 mutants that are unable to interact
with ARTD5 are associated with cherubism (Guettler et al.,
2011; Levaot et al., 2011). RNF146 was also found to protect
neuronal cells from glutamate excitotoxicity dependent on its
ability to interact with PAR (Andrabi et al., 2011). Thus, interac-
tion of different proteins to PAR controls local protein concentra-
tion and affects the activities of binding partners, which are key
consequences downstream of the activation of PAR-forming
ARTDs.
Whereas macrodomains are also capable of binding to ADP-
ribose (ADPr), WWE and PBZ domains require the a-(100–20)
O-glycosidic bond present in PAR for efficient interaction (Eu-
stermann et al., 2010; Karras et al., 2005; Wang et al., 2012).
A short linear peptide motif consisting of hydrophobic and
basic amino acids binds also to PAR. This motif was iden-
tified in several proteins, often related to DNA damage and
repair, transcription, replication, and chromatin structure (Gagne´
et al., 2008; Kleine and Lu¨scher, 2009; Pleschke et al., 2000).
Thus, PAR and its reader modules mediate protein-protein
interactions.
Several ARTD enzymes, exemplified by the MYC-binding
partner ARTD10 (Yu et al., 2005), function as mono-ADP-
ribosyltransferases in vitro (Di Paola et al., 2012; Kleine et al.,
2008). However, it is still unclear whether ARTD-mediated
mono-ADP-ribosylation (MARylation) exists in cells, althoughts reserved
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tional role of MARylation (Kleine et al., 2008). Several studies
have indicated MARylation of specific cellular proteins using
mainly indirect means and permeabilized cells, leaving open
whether extracellular mono-ADP-ribosyltransferases of the
ARTC family were involved in the modification (Dani et al.,
2009, 2011; Koch-Nolte et al., 2008; Lupi et al., 2000). The mac-
rodomain of Af1521 from Archaeoglobus fulgidus was used to
detect potentially MARylated proteins, but Af1521 also binds
to PAR (Dani et al., 2009; Guetg et al., 2012; Karras et al.,
2005). Moreover, it remains unclear whether intracellular reader
domains for MARylated substrates exist. Previously, macrodo-
mains were found to interact with free ADPr and with O-acetyl-
ADP-ribose, the product of deacetylation reactions catalyzed
by sirtuins, in addition to binding to PAR (Chen et al., 2011).
Structural analyses of different macrodomains revealed a highly
conserved ADPr-binding domain (Chen et al., 2011; Hassler
et al., 2011; Karras et al., 2005; Timinszky et al., 2009). However,
no structures of a macrodomain associated with an ADP-ribosy-
lated substrate are presently available. Reasons include that
PARylated substrates are heterogeneous and that MARylated
substrates are presently not available. Within the ARTD family,
ARTD8 (BAL2/PARP14), originally identified as B cell-aggressive
lymphoma (BAL) protein (Aguiar et al., 2000), contains three
macrodomains and a WWE domain besides the ADP-ribosyl-
transferase domain (see Figure 1A) (Aguiar et al., 2005). Similar
to ARTD8, ARTD9/BAL-1 and ARTD7/BAL-3 combine macrodo-
mains with ADP-ribosyltransferase domains (Aguiar et al., 2000;
Hottiger et al., 2010). Because ARTD8 is a mono-ADP-ribosyl-
transferase (Kleine et al., 2008), we hypothesized that a link
might exist between the ARTD8macrodomains andMARylation.
Therefore, we addressed whether the ARTD8 macrodomains
interact with ADPr and whether these domains serve as binding
modules for MARylated substrates.
We found that ARTD8 macrodomains specifically in-
teracted with mono-ADP-ribosylated substrates modified by
ARTD10 both in vitro and in cells, providing formal evidence
that endogenous MARylation exists in cells. The structure of
these macrodomains revealed a conserved fold for ADPr
binding, similar to other macrodomains. Despite this similarity,
ARTD8 macrodomains do not interact with ADPr polymers, indi-
cating that distinct macrodomains read either MARylated or
PARylated.
RESULTS
ARTD8 Macrodomains Bind Mono-ADP-Ribosylated
ARTD10
Although the ARTD10 mono-ADP-ribosyltransferase activity is
well documented in vitro (Kleine et al., 2008), it is less clear
whether MARylation by intracellular enzymes occurs in cells.
We noticed that ARTD10 colocalized with murine Artd8 in cells
upon transient expression (Figure 1B). Artd8 contains a WWE
domain and three macrodomains (Macro1–3) that might mediate
a possible interaction (Figure 1A). Homologs of both domains
have been shown to bind to PAR (Callow et al., 2011; Gottschalk
et al., 2009; Kang et al., 2011; Timinszky et al., 2009; Zhang et al.,
2011). Pull-down experiments revealed that Macro1–3, but not
Macro1 alone, nor the WWE domain, bound automodified butStructure 21,not unmodified ARTD10 (Figure 1C). Binding was specific and
dependent on b-NAD+ levels (Figure S1 available online), sug-
gesting that MARylation of ARTD10 is a prerequisite for binding.
In addition to Macro1–3, Macro2 and Macro3 also interacted
with automodified ARTD10 (Figure 1D). Similar results were ob-
tained with the macrodomains of human ARTD8 (Figure S1B).
The specificity of the interaction was further highlighted by the
absence of detectable binding of ARTD10(1–255) (Figure 1D),
which cannot be MARylated (Kleine et al., 2008). Also, the mac-
rodomain of histone macroH2A1.1 and its binding-deficient
mutant (G224E/F348A) did not interact with ARTD10 (Figure 1E),
but histone macroH2A1.1-bound PARylated ARTD1 as ex-
pected (Figure 1F) (Timinszky et al., 2009). In contrast, the
Artd8 macrodomains were unable to bind PARylated ARTD1
(Figure 1F). This indicates that specific macrodomains bind
either mono- or poly-ADP-ribosylated substrates.
We further validated the importance of ARTD10 MARylation
for its interaction with the Artd8 macrodomains. Macro1–3 was
unable to bind the catalytically inactive mutant ARTD10-
G888W (Figure 2A), and binding was substantially reduced
when the automodification reaction was performed in the pres-
ence of the ART inhibitor benzamide (Figure S1C). Finally, the
interaction with MARylated ARTD10 was subject to competition
by ADPr (Figures 2B and S1D). To address the specificity of the
macrodomains, we introduced the G1055E mutation into
Macro2. Mutation of the corresponding residue in the macrodo-
main of Af1521 interfered with ADPr binding (Dani et al., 2009).
This single amino acid exchange was sufficient to abrogate
binding to ARTD10 (Figure 2C).
Architecture of ARTD8 Macrodomains
To further evaluate the specific ADPr-binding ability of ARTD8’s
macrodomains, we solved the crystal structure of a protein
construct encompassing human ARTD8 macrodomains 1 and
2 (referred to asMacro1–2, residuesGly784–Ser1196) (Figure 3A;
Table 1). Each domain contained a central seven-stranded b
sheet flanked by two or three a helices on each side. The indi-
vidual domains packed tightly together forming an interface of
906 A˚2. The two domains interacted through 11 hydrogen bonds
and salt bridges as well as several hydrophobic contacts (Fig-
ure 3B). The complementary charges of their surfaces were
clearly visible in electrostatic surface potential maps (Figure 3C).
The affinities of each domain for ADPr were determined using
isothermal titration calorimetry (ITC). Macro1 bound free ADPr
with low affinity and Macro2 and 3 with high affinity (Tables 2
and S1; Figure S2), consistent with our pull-down experiments
shown above (Figure 1). For each particular domain, we deter-
mined similar binding constants regardless of whether single-,
tandem-, or triple-domain constructs were used (Table 2), indi-
cating that the individual domains did not cooperate. Thus,
ARTD8 macrodomains are ADPr-binding modules that do not
stand in allosteric contact with one another.
We determined the crystal structures of all three individual
ARTD8 macrodomains and also of ARTD7-Macro2 in complex
with ADPr (Figure 4; Table 1). Pairwise superposition showed
that all structures are very similar (Figure 4A): ARTD8-Macro3
and ARTD7-Macro2 (60% protein sequence identity) align to
a root mean square difference of 0.69 A˚ in Ca-atom positions,
whereas all other combinations of structures (10%–30% identity)462–475, March 5, 2013 ª2013 Elsevier Ltd All rights reserved 463
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Figure 1. Artd8 Macrodomains Interact with Mono-ADP-Ribosylated ARTD10
(A) Schematic representation of the ARTD8 domain architecture. Residue numbers refer to the human ortholog.
(B) EGFP-ARTD10 and FLAG-Artd8were transiently coexpressed in HeLa cells. The cells were fixed, stainedwith FLAG-specific antibodies (red), and analyzed by
confocal microscopy. Scale bar, 20 mM.
(C) Purified ARTD10 was automodified in the presence or absence of 500 mM b-NAD+ and subsequently incubated with the indicated bacterially expressed GST-
tagged Artd8 macrodomain or WWE domain. The complexes bound to glutathione Sepharose were analyzed by western blot analysis using ARTD10-specific
polyclonal antibodies (upper panel). For control, all blots were stained with Ponceau red.
(D) ARTD10 was incubated as in (C) and bound to bacterially expressed hexahistidine-taggedmacrodomains of Artd8. The complexes were recovered on TALON
beads and analyzed by western blot analysis using ARTD10-specific polyclonal antibodies (upper panel). The ADP-ribosylation reaction contained 5 mg of GST-
ARTD10(1–255), which was detected using GST-specific antibodies (middle panel).
(E) The experimental setup was as in (C) with the exception that GST-tagged mouse macroH2A1.1(126–369), encoding the macrodomain, and a mutant were
used in addition to the macrodomains of Artd8.
(legend continued on next page)
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Readers of Mono-ADP-Ribosylationaligned to between 1.3 and 1.6 A˚. A structure-based sequence
alignment is presented in Figure S3.
All of our macrodomain-ADPr complex structures display the
ligand well defined in the electron density maps (Figure 4B).
ADPr is bound in a deep surface groove on the ‘‘crest’’ of the
domain (Figure 4C), the outline of which is formed by two tight
turns and three extended loops (designated I–V in Figure 4D).
These loops appear more flexible than the overall domains, as
judged by higher experimental B factors. Comparison of an
apo structure of Macro3 and its ADPr complex reveals that these
loops open up slightly to accommodate the ligand (Figure S4).
The central part of the groove binds the pyrophosphates by
conserved interactions mainly with backbone atoms from
extended loops II and IV (Figures 4D–4F).
An aspartate side chain in loop V, which forms a hydrogen
bond with the adenine base nitrogen N6, was essential for
ADPr binding by the macrodomain of histonemacroH2A1.1 (Fig-
ure 4G) (Kustatscher et al., 2005). Our crystal structures show
that aspartate side chains fulfill the same function in Macro3
and in ARTD7-Macro2; by contrast, in Macro2, a nonconserved
glutamine (Gln1024 in loop I) hydrogen bonds with the adenine
N6 in a similar geometry. In Macro1, this interaction is entirely
missing because the base moiety is tilted out of the pocket
away from loop I (Figure 4D). Interactions between protein and
adenosine base are most extensive in Macro3, where the
hydrogen bondwith Asp1235 is complemented by a base-stack-
ing interaction with the Phe1371 side chain (Figure 4F). Base
stacking to a phenylalanine is also conserved in histone
macroH2A1.1 (Figure 4G) and ARTD7-Macro2; in Macro2, this
position is occupied by a histidine (Figure 4E). Together, these
differences in adenine base binding may be sufficient to explain
the differences in ligand affinities, in particular the notably
weaker affinity of Macro1 for ADPr (Table 2) and MARylated
ARTD10 (Figures 1D and 1E). The positions and orientations of
the adenine ribose and of the central pyrophosphates are similar
in all ARTD8 and ARTD7 macrodomain structures.
Active ARTD10 and the Macrodomains of Artd8 Interact
in Cells
Next, we investigated whether protein MARylation can be de-
tected in cells. Therefore, HeLa cells stably expressing inducible
ARTD10 or ARTD10-G888W were transiently transfected with
plasmids encoding EGFP-tagged Artd8 macrodomains, and
immunofluorescence imaging was performed. ARTD10 accumu-
lates in dot-like structures (Kleine et al., 2012). As soon as the
ARTD10 dots became visible, EGFP-Macro1–3, but not EGFP
alone, colocalized with these dots (Figure 5A). In contrast, no
colocalization between EGFP-Macro1–3 and the catalytically
inactive ARTD10-G888W was observable. EGFP-Macro2 and
EGFP-Macro3, but not EGFP-Macro1 and EGFP-Macro2-
G1055E, also colocalized with ARTD10, but not with ARTD10-
G888W (Figure S5). These findings were complemented by
coimmunoprecipitation experiments in HEK293 cells. Macro1–3
and Macro2, but not Macro2-G1055E, were capable to bind(F) Purified ARTD1 was automodified in the presence or absence of 500 mM b-NA
macrodomains of Artd8, GST-taggedmacroH2A1.1(162–369), or macroH2A1.1(1
ARTD1-specific polyclonal antibodies. The arrowhead identifies a nonspecific ba
See also Figure S1.
Structure 21,ARTD10 (Figure 5B). This demonstrated that Artd8 macrodo-
mains interact with ARTD10 in cells, providing evidence for
catalytic activity of intracellular ARTD10.
To exclude contributions of PAR-synthesizing ARTDs to the
interaction between ARTD10 and Artd8’s macrodomains in
cells, we conducted coimmunoprecipitation experiments in the
presence of Olaparib and IWR-1, which collectively inhibit
ARTD1–ARTD6 (Chen et al., 2009; Wahlberg et al., 2012).
Indeed, activation of ARTD1 was efficiently inhibited under these
conditions (Figure S6). Nonetheless, binding of EGFP-Macro1–3
to ARTD10 was not influenced (Figure 5C), suggesting that
PARylation does not play a role for the interaction.
Next, we investigated whether endogenous ARTD10 interacts
with the macrodomains of Artd8. Because HEK293 and HeLa
cells express only low amounts of ARTD10, we chose U2OS
cells. In these cells, IFN-a stimulates the ARTD10 promoter
(A.G., P.V., and B.L., unpublished data; Mahmoud et al., 2011),
allowing detection of endogenous ARTD10 protein (Figure 6A).
It also accumulated in dot-like structures that were more prom-
inent upon IFN-a stimulation, some of which were stained with
EGFP-tagged Macro1–3 (Figures 6A and 6B). Compared to the
overexpressed ARTD10, the ratio of colocalizing dots was
reduced, suggesting that ARTD10 was only active in some of
the dots (Figures 5 and 6).
In the presence of IWR-1 and Olaparib, consistent with the
coimmunoprecipitation experiments, colocalization between
endogenous ARTD10 and EGFP-Macro1–3 was not impaired
(Figures 6C, 6D, and S7A). Similarly, colocalization in the pres-
ence of the inhibitors was observed in HeLa cells that stably
express inducible ARTD10 (Figure S7B). No colocalization of
ECFP-macroH2A1.1(162–369) with endogenous ARTD10 dots
was detected (Figure S8). Thus, the macrodomains of Artd8
specifically recognize MARylated ARTD10 in cells.
Artd8 Macrodomains Bind Mono-ADP-Ribosylated
GTP-Bound RAN
Macrodomains of ARTD8 recognize ADP-ribosylated ARTD10
both in vitro and in cells, but not the unmodified protein. We
were now interested to evaluate whether any ARTD10 substrate
could be detected by macrodomains. Previously, we identified
core histones as in vitro substrates of ARTD10 (Kleine et al.,
2008). However, because core histones are known substrates for
ARTD1/PARP1, we decided to study other substrates. Because
many bacterial ADP-ribosylating toxins target small GTPases
(Di Girolamo et al., 2005), we tested whether the GTPases
RhoA,Ras, or Ranwere substrates of ARTD10.Of these proteins,
only Ran-GppNHp was specifically modified by ARTD10 (Fig-
ure 7A). Notably, binding of the nonhydrolyzable GTP analog
GppNHp to Ran induces a large conformational change in the
protein (Vetter et al., 1999), suggesting that this structural change
is a prerequisite for Ran modification by ARTD10.
Next, we determined whether MARylated Ran-GppNHp is
recognized by macrodomains. Pull-down experiments demon-
strated that Ran-GppNHp interacted with His-Macro1–3 orD+ and subjected to a pull-down assay with bacterially expressed GST-tagged
62–369)G224E/F348A. Bound proteins were analyzed bywestern blotting using
nd.
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Figure 2. Specificity of the Interaction between Mono-ADP-Ribosy-
lated ARTD10 and the Macrodomains of Artd8
(A) Purified ARTD10 and ARTD10-G888W were incubated in the presence or
absence of 500 mM b-NAD+. Binding of ARTD10 proteins to hexahistidine-
tagged Macro1–3 was measured by western blot analysis using ARTD10-
specific polyclonal antibodies (upper panel). For control, the blot was stained
with Ponceau red (lower panel).
(B) The experimental setup was as in (A). Automodified ARTD10 and His-
Macro1–3 were incubated in the presence of increasing amounts of ADPr. The
arrowhead identifies a nonspecific band.
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Incubation of Ran-GppNHp with ARTD10 in the absence of
b-NAD+ or with ARTD10-G888W did not result in macrodomain
binding. Thus,MARylated Ran is specifically recognized bymac-
rodomains. To evaluate whether Ran is MARylated in cells, HA-
ARTD10 and HA-ARTD10-G888W were transiently expressed in
HEK293 cells together with EGFP-tagged Artd8 macrodomains.
Ran was coimmunoprecipitated with EGFP-Macro1–3 and to
a lesser extent with EGFP-Macro3 in the presence of ARTD10
but not the catalytically inactive mutant (Figure 7D). Together,
these findings provide evidence that in cells, Ran is an
ARTD10 substrate that, if ADP-ribosylated, is recognized by
Artd8 macrodomains.DISCUSSION
Of the 17 protein ADP-ribosyltransferases (ARTDs) that exist in
mammalian cells (Hottiger et al., 2010), 9 have documented or
suggested MARylation activity (Kleine et al., 2008). Although
PAR formed by ARTD1 has been well documented by using
specific antibodies, it was unclear whether MARylation by
ARTDs occurs in cells due to the lack of suitable tools. We
now demonstrate that ARTD8 macrodomains are ADPr-binding
modules that detect ARTD10-dependent MARylated substrates
both in vitro and in cells. Thus, we provide formal evidence that
MARylation by an endogenous enzyme of the ARTD family
indeed exists in mammalian cells. Together, these findings
strongly suggest that MARylation is an intracellular posttransla-
tional modification that contributes to protein interaction and
crosstalk.
The specificity of the different ARTDs is only poorly under-
stood, and we cannot exclude the possibility that MARylated
substrates become available to polymer-forming enzymes in
cells. Moreover, PAR glycohydrolase (PARG), the enzyme
responsible for the majority of PAR breakdown in cells, cleaves
PAR but appears to be unable to remove the final ADPr unit
linked to the protein (Slade et al., 2011). Thus, transitions
between mono- and poly-ADP-ribosylation might occur on
potentially any given ARTD substrate. Hence, it was important
to establish evidence for the existence of MARylation in cells
and of domains that can distinguish between MAR and PAR.
Macro2 and Macro3 of Artd8 are such domains:
(1) Although Macro2 and Macro3 interacted with MARylated
but not PARylated substrates, the macrodomain of
macroH2A1.1, a reported PAR binder (Timinszky et al.,
2009), showed the reverse-binding specificity (Figures 1
and S8). If MARylated ARTD10 were substrate of poly-
mer-forming ARTDs and thus were PARylated, we would
have expected colocalization with the macrodomain of
macroH2A1.1.
(2) Only one distinct band of ARTD10 was coimmuno-
precipitated by Macro1–3 (Figure 5B). If ARTD10 was
PARylated in cells, we would have anticipated a more(C) The experimental setup was as in (A). Binding of ARTD10 was measured to
His-Macro2 or His-Macro2-G1055E, a mutant that is unable to bind to ADPr.
See also Figure S1.
ts reserved
Figure 3. Crystal Structure of the ARTD8 Macrodomains
(A) Crystal structure of a human ARTD8 Macro1 and Macro2 protein fragment.
ADPr-binding sites on opposite sides of the two-domain protein are indicated.
(B) Cartoon of the side chains that contribute to the interface between ARTD8
Macro1 (blue) and Macro2 (green). Water-mediated interactions are indicated
by blue lines, other polar interactions by black lines, and nonpolar interactions
by red lines.
(C) Surface rendering of calculated electrostatic potential, where red indicates
acidic and blue indicates basic sites. In the lower panel, the interface is shown
exposed by rotation of domains 1 and 2 by 90 to the left and right, respec-
tively, to illustrate matching buried surface charges.
See also Figure S3 and Table S2.
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Structure 21,diffuse band for PARylated ARTD10 due to the heteroge-
neous nature of ADPr polymers, rather than a single
protein band.
(3) Inhibition of ARTD1–ARTD4 by Olaparib and of ARTD5–
ARTD6 by IWR-1 did not influence the binding of Artd8’s
macrodomains to MARylated ARTD10 in cells (Figures
5C, 6B, and S7).
(4) Macro2 and Macro3, shown to be robust binders of
MARylated substrates of ARTD10 (Figures 1D, 1E, and
7), displayed no interaction with PARylated ARTD1
(Figure 1F).
Of note, human MacroD1 protein was recently shown to have
O-acetyl-ADP-ribose deacetylase activity (Chen et al., 2011).
Also, the catalytic domain of PARG possesses a macrodomain
fold (Slade et al., 2011). Moreover, and as discussed above,
macrodomains are interaction modules of PAR (Gibson and
Kraus, 2012). These findings suggest that macrodomains are
intimately involved in ADPr biology and metabolism. Contrasting
PARG, wewere unable to detect hydrolyzing activity of any of the
Artd8 macrodomains. In support, our crystal structures show
that none of the ARTD8 macrodomains features acidic side
chains that could serve to activate N-ribose hydroxyls for nucle-
ophilic attack (Figures 3D–3F). In addition, the interactions of
these macrodomains with MARylated ARTD10 and Ran as
seen in the pull-down and coimmunoprecipitation experiments
(Figures 1, 2, 5, and 7) are consistent with a lack of hydrolyase
activity. Thus, the three ARTD8 macrodomains are unable to
reverse MARylation of ARTD10. Together, our findings strongly
suggest that distinct macrodomains, despite their common
ability to bind free ADPr, possess specificity for binding to either
MARylated or PARylated substrates. In addition, some have
catalytic activity, defining macrodomains as key modules in
processing ADP-ribosylation (Figure 8).
Differential specificity of distinct macrodomains is also
supported by our crystal structures. These revealed different
conformations of the N-ribose, which are in local environments
where nonconserved side chains might contribute to the binding
sites of putative ADP-ribosylated target proteins. Also, a3 of
ARTD8-Macro3 is shorter by two helical turns than the corre-
sponding helices in any other macrodomain structure, resulting
in a more exposed site near the N-ribose (Figure 4F). These
observations underscore the general structural variability at
this position, which is consistent with target protein recognition
sites in proximity to the N-ribose. Although differences can
be noticed, it is important to point out that presently, no struc-
tures of a macrodomain with an ADP-ribosylated substrate pro-
tein are available. Thus, it remains unclear how macrodomains
are able to distinguish between MARylated and PARylated
substrates.
Thus far, the automodification sites within ARTD10 are not
known, except for E882 (Kleine et al., 2008). However, it is likely
that more than one site exists, similar to the findings with other
members of the ARTD family (Altmeyer et al., 2009; Tao et al.,
2009). Taking the possibility of several automodification sites
into account, this might explain the observation that the interac-
tion between ARTD10 and Macro1–3 was often apparently
stronger than between ARTD10 and either Macro2 or Macro3
alone (Figure 1). Furthermore, the existence of more than one462–475, March 5, 2013 ª2013 Elsevier Ltd All rights reserved 467
Table 1. Data Collection, Phasing, and Crystallographic Refinement Statistics
Data Collection
ARTD8m1
(ADPr)
ARTD8m2
(ADPr)
ARTD8m3
(apo)
ARTD8m3
(ADPr)
ARTD8m12
(ADPr)
ARTD8m12
(ADP)
ARTD7m2
(ADPr)
PDB 3Q6Z 3Q71 4ABL 4ABK 3VFQ 4D86 3V2B
Synchrotron BESSY MAX-II DIAMOND BESSY ESRF BESSY BESSY
Beamline BL14-1 I911-5 I02 BL14-2 ID14-4 BL14-1 BL14-2
Wavelength (A˚) 0.91841 0.90770 0.97950 0.91841 0.93928 0.91841 0.93928
Space group P43212 P3221 P212121 P212121 P2221 P2221 C2221
Unit cell dimensions
a (A˚) 71.36 66.35 33.71 32.95 46.62 46.60 68.10
b (A˚) 71.36 66.35 41.07 41.25 59.94 60.03 91.19
c (A˚) 71.44 110.69 108.92 108.54 144.34 145.07 62.85
a () 90 90 90 90 90 90 90
b () 90 90 90 90 90 90 90
g () 90 120 90 90 90 90 90
Resolution (A˚) 35.0–2.20
(2.26–2.20)
30.0–2.20
(2.30–2.20)
35.0–1.15
(1.18–1.15)
35.0–1.60
(1.64–1.60)
30.0–2.80
(2.87–2.80)
50.0–2.00
(2.05–2.00)
35.0–2.20
(2.26–2.20)
No. of unique reflections 9,427 (667) 14,842 (1,824) 53,461 (3,305) 18,999 (1,331) 10,295 (750) 28,298 (2,043) 10,255 (740)
Rmerge (%)
a 9.3 (62.3) 14.9 (58.4) 5.3 (43.4) 4.2 (26.8) 12.1 (74.4) 6.3 (66.7) 12.7 (55.3)
Completeness (%) 99.8 (99.7) 99.9 (99.9) 97.8 (82.7) 93.7 (64.5) 99.9 (99.7) 99.9 (99.9) 100 (100)
Redundancy 11.8 (12.2) 9.0 (9.1) 6.7 (4.9) 13.7 (10.9) 8.3 (7.6) 7.1 (6.9) 7.2 (7.2)
<I/sI> 26.6 (6.8) 14.0 (4.2) 20.9 (3.9) 43.8 (9.6) 10.1 (2.3) 24.6 (3.2) 13.9 (4.4)
Phasing
MR starting model 1SPV 3IID – 3V2B 3Q6Z, 3Q71 – 1SPV
Refinement
Resolution (A˚) 31.9–2.23 28.7–2.20 32.8–1.15 32.8–1.60 46.6–2.80 39.2–2.00 34.0–2.20
Rall (%)
b 21.18 19.09 16.22 16.83 23.79 19.93 17.87
Rfree (%)
b 27.84 22.27 19.13 20.64 28.31 23.82 24.09
Rmsd bond length (A˚) 0.018 0.010 0.017 0.015 0.013 0.012 0.017
Rmsd bond angle () 1.8 1.3 1.6 1.5 1.5 1.3 1.9
Ramachandran plot c
Favored (%) 97.3 98.5 98.3 98.3 94.3 98.4 97.2
Allowed (%) 100 100 100 100 100 100 100
Values in parentheses are for the outermost resolution shell. See also Table S2.
aRmerge =
P jI hIij=P I, where I is the intensity measurement for a given reflection, and hIi is the average intensity for multiple measurements of this
reflection.
bR =
P jjFobsj  jFcalcjj=
P jFobsj, where Rfree is calculated for a randomly chosen 5%–10%of reflections, which were not used for structure refinement,
and Rall is calculated for all reflections.
cThe Ramachandran plot was calculated using the MolProbity server (http://molprobity.biochem.duke.edu/) (Davis et al., 2007).
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Readers of Mono-ADP-Ribosylationautomodification site might be a reason for the altered binding of
Macro2 and Macro3, i.e., Macro3 bound more efficiently in vitro
and Macro2 in cells to automodified ARTD10 (Figures 1 and 5).
It is conceivable that these twomacrodomains interact preferen-
tially with distinct MARylated sites on ARTD10, which might be
differentially modified in vivo and in vitro. This could be the result
of interacting proteins in cells that are not present in the in vitro
assays with purified components. This differential binding may
also reflect that the two macrodomains recognize MARylation
in slightly different contexts. Either the underlying peptide
sequence and/or structural differences of the individual sites
are likely to contribute to the interaction. The findings that
ADPr is a rather poor competitor for binding of macrodomains
to automodified ARTD10 (Figures 2B and S1D) and that neither
Macro2 nor Macro3 binds to poly-ADP-ribosylated ARTD1468 Structure 21, 462–475, March 5, 2013 ª2013 Elsevier Ltd All righ(Figure 1F) support this conclusion. Also notable is that the
endogenous ARTD10 only colocalizes to a certain extent with
Macro1–3, especially if the expression was not enhanced by
IFN-a treatment. One explanation might be that only a subpopu-
lation of ARTD10 is active in cells, and/or stimuli are required to
enhance the catalytic activity.
In signaling events, specific recognition of modified target
proteins by a reader domain is essential (Hunter, 2007). Addition-
ally, combinatorial effects are key to define specificity and
stability of interactions, potentially requiring the correct
spatial orientation of specific reader domains and/or combina-
tions of posttranslational modifications. As an example, recruit-
ment of the NURF complex to chromatin depends on the
correct alignment of the PHD finger and the bromodomains of
BPTF, which recognize H3K4me2/H3K4me3 and H4K16ac,ts reserved
Table 2. ITC to Determine the ADPr-Binding Properties of ARTD8
Macrodomain Protein Constructs
ARTD8 Construct Protein
KD
app (mM); ITC
First Second Third
Macrodomain 1 192 ± 7 – –
Macrodomain 2 6.0 ± 0.1 – –
Macrodomain 3 1.9 ± 0.1 – –
Macrodomain 1+2a 6.4 ± 0.2 261 ± 30 –
Macrodomain 2+3a 1.84 ± 0.45 12.6 ± 0.9 –
Macrodomain 1+2+3a 1.2 ± 0.04 18.7 ± 0.3 273 ± 4.3
See also Figure S2 and Table S1.
aExperimental data were fitted to an independent-site model (n = 1).
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Readers of Mono-ADP-Ribosylationrespectively (Ruthenburg et al., 2011). Thus, an important ques-
tion to address in the future is whether the ARTD8 macrodo-
mains and theWWEdomain cooperate in recognizing interaction
partners and substrates. The fundamental finding of a tool to
investigate MARylation by ARTD10 will allow future studies to
define endogenous ARTD10 substrates and to address the
physiological relevance, for example for Ran, of MARylation.Figure 4. ADPr Binding of ARTD8 Macrodomains
(A) Superposition of the crystal structures of individual ADPr-bound ARTD8 macr
(gray).
(B) Stereo image of the electron density (2FobsFcalc map calculated using REFM
the ligand-binding site in Macro3.
(C) Surface of Macro3 rendered to illustrate the ADPr-binding grove and surroun
(D–G) Details of the interactions between protein and ADPr as seen in the crysta
histone macroH2A domain of AF1521 (PDB 2BQF) (G).
See also Figures S3 and S4.
Structure 21,EXPERIMENTAL PROCEDURES
Molecular Cloning
All ARTD10 (PARP10) constructs have been described previously (Kleine et al.,
2008). The cDNAs encoding human ARTD8/BAL2 (Q460N5) and ARTD7/BAL3
(Q460N3) were obtained from the National Institute of Technology and
Evaluation, Japan (accession number AK304269) and the Mammalian Gene
Collection (accession number BC101701), respectively. The X-ray crystallog-
raphy and ITC experiments, the regions encoding ARTD8 residues Gly789–
Lys979 (macrodomain-1; hereafter calledMacro1), Gly999–Ser1196 (Macro2),
Phe1208–Gly1388 (Macro3), Gly784–Ser1196 (Macro12), Ala994–Gly1388
(Macro23), Ser794–Ser1393 (Macro123), and ARTD7 residues Thr272–
Asn448 (ARTD7-Macro2) were amplified by PCR and inserted into bacterial
expression vector pNIC28-Bsa4 by ligation-independent cloning (Gileadi
et al., 2008). All expression constructs encoded an N-terminal hexahistidine
tag separated from the target protein by a tobacco etch virus (TEV) pro-
tease cleavage site. For additional clonings, see Supplemental Experimental
Procedures.
Antibodies
We purchased antibodies specific for GFP (600-301-215; Rockland), Ran
(ab13049; Abcam), Flag (M2; Sigma-Aldrich), ARTD1 (1835238; Roche), PAR
(10H, 1020; Tulip Biolabs), GAPDH (4G5, MCA4740; AbD Serotec), and Actin
(C4; MP Biomedicals). The ARTD10-specific antibody is a purified polyclonal
serum derived from rabbit immunized with the ARTD10(206–255) fragment.odomains 1 (blue), 2 (green), and 3 (salmon), as well as ARTD7 macrodomain 2
AC5 [Murshudov et al., 2011] and rendered at 1.8s) and the resulting model for
ding charge distribution.
l structures of ARTD8 Macro1 (D), ARTD8 Macro2 (E), ARTD8 Macro3 (F), and
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Figure 5. Artd8 Macrodomains Interact with ARTD10 in Cells
(A) HeLa cells stably expressing inducible ARTD10 or ARTD10-G888W were transiently transfected with EGFP-Macro1–3. The localization of EGFP-Macro1–3
and ARTD10 before and after induction was analyzed by confocal microscopy. Scale bar, 20 mM. The panels on the right show enlargements of the indicated
merged images.
(B) HA-ARTD10, HA-ARTD10-G888W, and the indicated EGFP-fusion proteins were expressed transiently in HEK293 cells. The cells were then lysed and EGFP-
containing complexes immunoprecipitated (IP). ARTD10 associated with the different EGFP-fusion proteins were analyzed by western blot analysis (mAb 5H11,
upper panel). The different EGFPs are shown in the lower panel. TCL, total cell lysates with expression of ARTD10 and GAPDH as control. The arrowhead
identifies a nonspecific band.
(C) The experiment was carried out as in (B). The indicated samples were treated with 2 mM IWR-1 for 24 hr and with 10 mMOlaparib for 2 hr prior to cell lysis. The
arrowhead identifies a nonspecific band.
See also Figures S5, S6, and S8.
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Figure 6. Artd8 Macrodomains Colocalize with Endogenous ARTD10 in Cells
(A) U2OS cells were transiently transfected with EGFP or EGFP-Macro1–3. The indicated samples were treated with IFN-a for 24 hr. ARTD10 was stained using
polyclonal antibodies and secondary antibodies coupled to Alexa Fluor 555. Nuclei were stained with Draq5. Colocalization with and without IFN-a treatment was
analyzed by confocal microscopy. Scale bar, 20 mM. An enlargement of the displayed merge picture is shown on the right. The red arrow specifies the location of
the colocalization profile shown in (B).
(B) Colocalization profile of ARTD10 and EGFP-Macro1–3. The distance of 14 mM corresponds to the length of the red arrow in (A).
(C) The experimental setup was as in (A) with the exception that the indicated samples were treated with 2 mM IWR-1 for 24 hr and with 10 mM Olaparib for 2 hr
before fixation and staining of the cells.
(D) Colocalization profile of ARTD10 and EGFP-Macro1–3 after inhibitor treatment. The distance of 14 mM is represented by the red arrow in the enlarge-
ment in (C).
See also Figures S6–S8.
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A C
D
B
Figure 7. Artd8 Macrodomains Interact with Mono-ADP-Ribosylated Ran, an ARTD10 Substrate
(A) The indicated bacterially expressed GTPases (Ran, Ras, and Rho) were used as substrates in ADP-ribosylation assays with 32P-b-NAD+. Ran was either
unloaded or loaded with GDP or GppNHp, a nonhydrolyzable GTP analog. The upper panels show Coomassie blue-stained gels, the lower panels autoradio-
graphs.
(B and C) Ran-GppNHp was incubated with ARTD10 or ARTD10-G888W in the presence or absence of 500 mM b-NAD+. The interaction of ARTD10 and
Ran with His-Macro1–3 (B) and His-Macro3 (C) was determined by western blot analysis. For control, the blot was stained with Ponceau red (lower
panel in B).
(D) HA-ARTD10 or HA-ARTD10-G888Wwas expressed transiently together with the indicated EGFP-fusion proteins in HEK293 cells. Upon lysis, the EGFP-fusion
proteins were immunoprecipitated with specific antibodies, and the bound proteins were analyzed by western blotting (upper panel). For control, the expressed
proteins and endogenous Ran and actin were stained (lower panel).
Structure
Readers of Mono-ADP-RibosylationThe monoclonal antibody 5H11 of rat IgG subclass recognizes ARTD10(300–
350). The GST-specific antibody is a monoclonal antibody derived from a rat
immunized with GST (mAb 6G9).
Macrodomain His-/GST-Pull-Down Experiments
All His-/GST-tagged proteins were purified using standard protocols as
described in the Supplemental Experimental Procedures. A total of 5 mg of
purified His-tagged macrodomains was preincubated with 25 ml equilibrated472 Structure 21, 462–475, March 5, 2013 ª2013 Elsevier Ltd All righTALON Metal Affinity Resin (BD Biosciences) in 350 ml IMAC lysis/wash
buffer containing 10 mM imidazole at 4C for 2 hr. Afterward, the beads
were washed twice with ice-cold IMAC lysis/wash buffer. ADP-ribosyltransfer-
ase assays were performed in 30 ml ADPr buffer (50 mM Tris [pH 8.0],
0.2 mM DTT, and 4 mM MgCl2) and 500 mM b-NAD
+ with 0.5 mg TAP-purified
ARTD10 or ARTD10-G888W under permanent agitation at 30C for 30 min.
Where applicable, 5 mg of GST-ARTD10(1–255) or 1 mg of the respective
Ran-GTPase as a substrate was added to the ADPr assay. The generalts reserved
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Figure 8. Summary of Macrodomain
Functions
Scheme illustrating binding or catalytic properties
of different macrodomain types. One representa-
tive for each type is indicated: (1) as a common
feature, most macrodomains bind ADPr, albeit
with variable affinities; (2) binding of MARylated
proteins; (3) binding of PARylated proteins; (4)
hydrolysis of PAR chains; and (5) hydrolysis of
OAADPr.
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the indicated concentrations. Then the ADPr assays were incubated with the
TALON Metal Affinity Resin and the prebound macrodomains at 4C for 2 hr,
together with 350 ml IMAC lysis/wash buffer and 10 mM imidazole. In the
samples with Ran-GppNHp, 20 mM imidazole was included. Western blots
were evaluated using the Fujifilm LAS-3000 imaging system and processed
using Adobe Photoshop.
A total of 5 mg of GST or GST-tagged macrodomain or WWE-domain
proteins of Artd8 or GST-tagged macroH2A1.1(162–369) proteins was preab-
sorbed onto 25 ml of glutathione Sepharose (Sigma-Aldrich) in the presence of
350 ml pull-down buffer (100 mM Tris-HCl [pH 7.6], 250 mM NaCl, 50 mM KCl,
5 mM MgCl2, 0.5% NP-40, 1 mM DTT, 0.5 mM EDTA, 10% glycerol, and
protease inhibitors) at 4C for 2 hr. An ADPr assay with 0.5 mg TAP-purified
ARTD10 or 0.3 mg baculo-derived His-purified ARTD1 in the absence or pres-
ence of 50 mM or 500 mM b-NAD+ was performed as described above. Next,
modified or unmodified ARTD10 or ARTD1 was incubated with the WWE/
macrodomain-glutathione Sepharose beads in 350 ml of pull-down buffer.
Complexes were subsequently analyzed by western blotting with specific
antibodies.
Purification of TAP-Tagged ARTD10/ARTD10-G888W and
Enzymatic ADP-Ribosyltransferase Assays
The purification of ARTD10 and mutants and the enzymatic ADP-ribosyltrans-
ferase assays were performed as described before (Kleine et al., 2008).
Equipment and Settings for Immunofluorescence Microscopy
Cells were fixed by 3.8% paraformaldehyde, permeabilized with 0.1%
Triton X-100 in PBS, and blocked by preincubation in PBS containing 0.1%
Triton X-100 and 1% BSA at room temperature for 30 min. Fixed cells were
stained with antibodies specific for the Flag epitope (M2) or for ARTD10
(mAb 5H11), diluted 1:100 in PBS containing 0.2% BSA (PBS/BSA) at
37C for 1 hr. Further details are given in the Supplemental Experimental
Procedures.
Immunofluorescence images were captured by a Zeiss Axiovert 100 M
confocal laser-scanning microscope (LSM 510) or a Zeiss LSM 710 laser-
scanning microscope. All details are given in the Supplemental Experimental
Procedures.
Coimmunoprecipitations
HEK293 cells were transiently cotransfected with constructs expressing
EGFP-tagged macrodomains and HA-ARTD10 or HA-ARTD10-G888W as
indicated using the calcium phosphate coprecipitation method (Bousset
et al., 1994). Forty-eight hours after transfection, cells were harvested and
lysed in TAP-lysis buffer (Kleine et al., 2008). EGFP-fusion proteins wereStructure 21, 462–475, March 5, 2013immunoprecipitated, and the bound proteins
were analyzed by western blots using the indi-
cated antibodies. For experiments where the
inhibitors Olaparib and IWR-1 were used, cells
were treated with 2 mM of IWR-1 24 hr after trans-
fection for the following 24 hr. Olaparib was added
to the cells at a concentration of 10 mM for 2 hr
before lysis of the cells.
The functionality of Olaparib was tested by
treating HEK293 cells with or without 2 mM ofIWR-1 for 24 hr and 10 mM Olaparib for 2 hr. ARTD1 was induced in the
indicated samples by addition of 1 mM H2O2 for 10 min. Subsequently, cells
were lysed in sample buffer, and western blot analysis with specific PAR
antibodies (10H) was performed.
Protein Purification for Crystallization and ITC Experiments
Amino-terminal hexahistidine fusions of human macrodomain protein con-
structs were expressed in E. coli and purified using standard methodology,
as detailed in the Supplemental Experimental Procedures.
Crystallization
Crystals were grown by the sitting drop vapor diffusion method. Where
applicable, ligands were preincubated with the protein solutions prior to
setting up drops. Details of the crystallization conditions are summarized in
Table S2.
Data Collection, Phasing, and Refinement
Crystals were transferred to a cryoprotectant solution (well solution supple-
mented with either glycerol or butanediol) and cooled and stored in liquid
nitrogen. Details on data collection, phasing using molecular replacement,
refinement procedures, and statistics are given in Table 1. Data were indexed
and integrated using the XDS package (Kabsch, 2010) or the autoPROC
toolbox (Vonrhein et al., 2011). Balbes (Nichols et al., 2008) or MOLREP (Vagin
and Teplyakov, 2010) was used for molecular replacement. Model building
was done with Coot (Emsley et al., 2010) and refinement with REFMAC5 (Mur-
shudov et al., 2011). The refinement progress was monitored by decreasing
R and Rfree values.
The structure of ARTD8-Macro2 (3Q71) featured an extended b-loop-b
structure, formed partially from residues in the hexahistidine affinity tag, at
the N terminus. This motif has not been observed in any other macrodomain
structure and is likely a cloning artifact.
ITC
ARTD8 macrodomain proteins were dialyzed overnight in 20 mM HEPES
(pH 7.5), 300 mM NaCl, 10% glycerol, and 2 mM TCEP. Protein concentra-
tion after dialysis was determined using extension coefficients calculated
from the protein construct sequences. ITC was performed at 25C using
an ITC200 microcalorimeter (MicroCal; GE Healthcare Life Sciences). A
protein solution (39–50 mM) was loaded into the sample cell and titrated
with ADPr (0–500 mM) at a stirring rate of 1,000 rpm. Results were analyzed
with Origin software (MicroCal). The observed values for binding enthalpy
were corrected for heat of dilution of ligand into the buffer and fitted to
one-site and independent-site-binding models, as indicated in Tables 2
and S1.ª2013 Elsevier Ltd All rights reserved 473
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Coordinates have been deposited into the Protein Data Bank with accession
codes 3Q6Z (ARTD8macrodomain-1 ADPr complex), 3Q71 (ARTD8macrodo-
main-2 ADPr complex), 4ABL (ARTD8 macrodomain-3 apo protein), 4ABK
(ARTD8 macrodomain-3 ADPr complex), 3VFQ (ARTD8 macrodomain-1 apo,
macrodomain-2 ADPr complex), 4D86 (ARTD8 macrodomain-1 ADP, macro-
domain-2 ADP complex), and 3V2B (ARTD7 macrodomain-2 ADPr complex).
SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.str.2012.12.019.
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